Q1: Mr. Rea: In your description of equipoise (In the book Chemical Muscle Enhancement) you said that long-term use of this AAS for a lengthy protocol gave you an "unfavorable CBC result." What kind of result is this and how long is too long to remain on EQ.
A1: I neither endorse nor condemn the use of AAS (Anabolic Androgenic Steroid) and related chemistries though I have dedicated many years to understanding their unique mechanisms. However, I do have a real problem with issues of health sabotaging protocols destructive simply by design without forethought. Maximum progress can be obtained without tempting death.
A simple CBC (Complete Blood Count) can help anyone avoid health problems of many origins…not only from AAS use.
In the case of boldenone (Equipoise), the length of administration resulting in excessive and dangerous red blood cell count was dose dependent. Most have shown only acceptable upregulation at dosages of 200-400mg/w (@ 1-2mg per pound of bodyweight) for up to 12 weeks. However, dosages of 600-800mg/w (3-4mg per pound of body weight) usually resulted in exceeding the upper "safer" levels for red blood cell count after only 4-6 weeks of employment. This is a real concern. Red blood cell count elevation can result in blood clots, strokes and circulatory depreciation.
Many precontest athletes using longer AAS protocols have avoided this concern by using:
1.Lower dosages.
2.A 50/25/25 division between boldenone/nandrolone/Masteron (nandrolone draws water and Masterone mediates it).
3.Using the higher dosage range only the last 4 weeks precontest.
A1: I neither endorse nor condemn the use of AAS (Anabolic Androgenic Steroid) and related chemistries though I have dedicated many years to understanding their unique mechanisms. However, I do have a real problem with issues of health sabotaging protocols destructive simply by design without forethought. Maximum progress can be obtained without tempting death.
A simple CBC (Complete Blood Count) can help anyone avoid health problems of many origins…not only from AAS use.
In the case of boldenone (Equipoise), the length of administration resulting in excessive and dangerous red blood cell count was dose dependent. Most have shown only acceptable upregulation at dosages of 200-400mg/w (@ 1-2mg per pound of bodyweight) for up to 12 weeks. However, dosages of 600-800mg/w (3-4mg per pound of body weight) usually resulted in exceeding the upper "safer" levels for red blood cell count after only 4-6 weeks of employment. This is a real concern. Red blood cell count elevation can result in blood clots, strokes and circulatory depreciation.
Many precontest athletes using longer AAS protocols have avoided this concern by using:
1.Lower dosages.
2.A 50/25/25 division between boldenone/nandrolone/Masteron (nandrolone draws water and Masterone mediates it).
3.Using the higher dosage range only the last 4 weeks precontest.
